New Key Statistics Module, Z-Score and F-Score
NAS:SANA Key Ratios
Market Cap $ M | 1,933.72 |
Enterprise Value $ M | 1,728.73 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 5.15 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -1.53 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -5.41 |
EV-to-EBITDA | -5.84 |
PEG | -- |
Shares Outstanding M | 221.50 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 6.07 |
Current Ratio | 6.07 |
ROA % (ttm) | -46.31 |
ROE % (ttm) | -85.17 |
ROIC % (ttm) | -78.41 |
Dividend Yield % | -- |
Altman Z-Score | -- |
SANA Number of Guru Trades
SANA Volume of Guru Trades
Gurus Latest Trades with NAS:SANA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SANA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sana Biotechnology Inc Insider Transactions
No Available Data
News about NAS:SANA
Total 0- 1